TECHNOLOGY TRANSFER & COMMERCIALIZATION

The New York State Center of Excellence in Bioinformatics & Life Sciences (CoE) is oriented toward translational research, technology transfer, and commercialization supported by a rich history of discovery among scientists at CoE research institutions include:

• BAC Libraries for Sequencing the Human Genome
• Platinum Coil for Inoperable cranial Aneurysms
• Prostate-Specific Antigen (PSA) Test
• Surfactant Replacement Therapy for Neonatal Respiratory Distress
• Photodynamic Therapy for Cancer
• Beta-Interferon Therapy for Multiple Sclerosis
• Nicotine Replacement Therapy
• Sickle Cell Screening Test
• High-Throughput Crystallization Method
• Timed-Release Insulin Therapy

Working closely with its commercialization partners, the CoE is geared toward leveraging its research capabilities to create new technological advantages for health care and life sciences industry sectors, including biotechnology, biomedical informatics, diagnostics, medical devices, pharmaceuticals and research & development.

 

 

Center for Advanced Technology (CAT)

The State University of New York at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT), one of fifteen such Centers for Advanced Technology located across the state, supports university-industry collaboration in research, education and technology transfer, with a strong focus on helping New York State-based businesses gain a technological edge on their competition. Operating under the auspices of the New York State Office of Science, Technology and Academic Research (NYSTAR) within the CoE, the CAT is fueling continued growth in some of the most promising technologies of tomorrow and in some of the most important sectors of the state's economy. The UB CAT focuses on biomedical and bioengineering research that can lead to development of useful products with commercial potential. By accelerating science and technology transfer, the UB CAT fosters the creation of new biotech start-up companies and helps existing biomedical businesses expand through new or improved product lines. For more information on the UB CAT program, click here.

The UB CAT is currently accepting applications for support of the development of new biomedical and bioengineering technologies. Through the support of selected research and development projects, the mission of the UB CAT award is to transition new biomedical and bioengineering technologies from the research laboratory to the marketplace through funding of high-tech projects with significant potential for economic impact.

If you are a researcher or entrepreneur who needs assistance with technology and related business development, please visit the UB CAT webpage and download the CAT Project Application.

Technology Transfer Programs

University at Buffalo Office of Science, Technology Transfer and Economic Outreach (STOR) has three divisions, including Intellectual Property, Funding and Commercialization, to work with business leaders, researchers and entrepreneurs. UB technologies may also be reviewed online (click here)

Roswell Park Cancer Institute Technology Transfer Office facilitates the process of applying for patents, trademarks and copyright, as well as promoting licensing opportunities.

Other Commercialization Support

A robust network of entrepreneurial support resources work closely with the CoE to accelerate the process of life sciences technology transfer and commercialization.

• Buffalo Biosciences
• Buffalo Niagara Enterprise
• Erie County Industrial Development Agency
• First Wave Technologies
• Insyte Consulting
• University at Buffalo School of Management

 

News

Buffalo Niagara Medical Campus to Revamp Trico Site
07/19/2008 - BUFFALO, N.Y. -- Armed with a $4.5 million cash transfusion, the Buffalo Niagara Medical Campus is pushing ahead with a key physical expansion.  Patrick Whelan, BNMC chief operating officer, said funding approved last week by the Empire State Development Corp. will aid a $12 million effort to turn a portion of the former Trico windshield wiper plant into a high-tech innovation center...[Read On...]

Quantum Rod System May Safely 'Sneak' Drugs, Diagnostics into Brain
07/16/2008 - BUFFALO, N.Y. -- A unique nanoparticle system developed by University at Buffalo scientists takes advantage of the versatility of bioconjugated quantum rods to ferry novel diagnostic and therapeutic agents across the blood-brain barrier, according to recent in vitro findings. Described in a paper published in Bioconjugate Chemistry, the system uses the rod-shaped semiconductor nanoparticles that are bioconjugated, or coupled, with biomolecules capable of crossing the blood-brain barrier...[Read On...]

Visit the News Archive

Events

September 23, 2008 - MedTech08 Biosciences Summit
Growing, Changing, Booming: Adapting healthcare to the needs of an aging population.  Join us at The Lodge in Skaneateles NY for this exciting daylong event packed with industry leaders sharing their strategies for successfully adapting to the aging boomer demographic.  To learn more and register, Click here

October 27-28, 2008 - AACR Centennial Symposium
Roswell Park Cancer Institute is hosting the American Association for Cancer Research (AACR) Centennial Symposium, entitled “The Future of Cancer Research: Science and Patient Impact”, this fall.  To learn more and register, Click here.

To view the complete list of events and event details, please visit our Events page

To receive periodic News & Events emails from the COE, please join our mailing list!